Pediatric psychopharmacology : principles and practice /

This is a comprehensive text on the use of medication in the treatment of children and adolescents with serious neuropsychiatric disorders. It reconciles recent research findings with good clinical practice.

Saved in:
Bibliographic Details
Online Access: Full text (MCPHS users only)
Other Authors: Martin, Andrés (Editor)
Format: Electronic eBook
Language:English
Published: Oxford ; New York : Oxford University Press, 2003
Subjects:
Local Note:ProQuest Ebook Central

MARC

LEADER 00000cam a22000004a 4500
001 in00000277079
006 m o d
007 cr cnu---unuuu
008 060110s2003 enka ob 001 0 eng d
005 20240703135927.0
019 |a 646787604  |a 764507641  |a 880305265  |a 961629176  |a 962692474  |a 966199058  |a 988474321  |a 991919982  |a 991985985  |a 1035670341  |a 1037718449  |a 1038633854  |a 1045498350  |a 1055403192  |a 1058153991  |a 1058532607  |a 1064968589  |a 1097130224  |a 1153499514  |a 1228564365  |a 1300444066 
020 |a 1423745698  |q (electronic bk.) 
020 |a 9781423745693  |q (electronic bk.) 
020 |z 0195141733  |q (cloth ;  |q alk. paper) 
020 |a 1280835044 
020 |a 9781280835049 
020 |a 6610835047 
020 |a 9786610835041 
020 |a 0198032455 
020 |a 9780198032458 
029 1 |a AU@  |b 000051587551 
029 1 |a DEBBG  |b BV043074682 
029 1 |a DEBBG  |b BV044122305 
029 1 |a DEBSZ  |b 422292516 
029 1 |a GBVCP  |b 801382157 
029 1 |a NZ1  |b 13858791 
035 |a (OCoLC)62866815  |z (OCoLC)646787604  |z (OCoLC)764507641  |z (OCoLC)880305265  |z (OCoLC)961629176  |z (OCoLC)962692474  |z (OCoLC)966199058  |z (OCoLC)988474321  |z (OCoLC)991919982  |z (OCoLC)991985985  |z (OCoLC)1035670341  |z (OCoLC)1037718449  |z (OCoLC)1038633854  |z (OCoLC)1045498350  |z (OCoLC)1055403192  |z (OCoLC)1058153991  |z (OCoLC)1058532607  |z (OCoLC)1064968589  |z (OCoLC)1097130224  |z (OCoLC)1153499514  |z (OCoLC)1228564365  |z (OCoLC)1300444066 
035 |a (OCoLC)ocm62866815  
040 |a N$T  |b eng  |e pn  |c N$T  |d OCLCQ  |d TUU  |d OCLCQ  |d E7B  |d OCLCQ  |d OCLCF  |d OCLCO  |d NLGGC  |d OCLCQ  |d SLY  |d YDXCP  |d EBLCP  |d OCLCQ  |d AZK  |d LOA  |d OCLCO  |d OCLCA  |d AGLDB  |d TOA  |d OCLCO  |d MOR  |d PIFAG  |d PIFBR  |d ZCU  |d OCLCO  |d MERUC  |d OCLCO  |d OCLCQ  |d OCLCO  |d WY@  |d OCLCO  |d OCLCA  |d U3W  |d OCLCO  |d OCLCA  |d LUE  |d OCLCO  |d STF  |d WRM  |d OCLCQ  |d VTS  |d ICG  |d VT2  |d OCLCQ  |d AU@  |d INARC  |d WYU  |d TKN  |d OCLCO  |d DKC  |d OCLCQ  |d OCLCO  |d UX1  |d HS0  |d OCLCQ  |d OCLCA  |d UKCRE  |d OCLCA  |d UKAHL  |d OCLCO  |d OCLCQ  |d OCL  |d YDX  |d OCLCO  |d OCLCL  |d CSG  |d SXB 
050 4 |a RJ504.7  |b .P397 2003eb 
060 4 |a 2003 B-108 
060 4 |a WS 350.2  |b P371 2003 
072 7 |a MED  |x 093000  |2 bisacsh 
072 7 |a MED  |x 105020  |2 bisacsh 
082 0 4 |a 615/.78  |2 22 
084 |a R749. 94  |2 clc 
245 0 0 |a Pediatric psychopharmacology :  |b principles and practice /  |c edited by Andrés Martin [and others]. 
260 |a Oxford ;  |a New York :  |b Oxford University Press,  |c ©2003. 
300 |a 1 online resource (xx, 791 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
504 |a Includes bibliographical references and index. 
505 0 |a Contributors; SECTION I: BIOLOGICAL BASES OF PEDIATRIC PSYCHOPHARMACOLOGY; I-A: DEVELOPMENTAL PRINCIPLES OF NEUROBIOLOGY AND PSYCHOPHARMACOLOGY; 1. Overview of Brain Development; 2. Synaptic Function and Biochemical Neuroanatomy; 3. Mechanisms of Signal Transduction and Adaptation to Psychotropic Drug Action; 4. Pharmacokinetics I: Developmental Principles; 5. Pharmacokinetics II: Cytochrome P450-Mediated Drug Interactions; I-B: GENETIC PRINCIPLES; 6. Molecular Genetics; 7. Pharmacogenetics; I-C: DEVELOPMENTAL PSYCHOPATHOLOGY 
505 8 |a 8. Neurobiology of Attention Regulation and its Disorders9. Neurobiology of Early-Life Stress and its Disorders; 10. Neurobiology of Early-Onset Mood Disorders; 11. Neurobiology of Early-Onset Anxiety Disorders; 12. Neurobiology of Obsessive-Compulsive Disorder; 13. Neurobiology of Tic Disorders, Including Tourette's Syndrome; 14. Neurobiology of Immune-Mediated Neuropsychiatric Disorders; 15. Neurobiology of Childhood Schizophrenia and Related Disorders; 16. Neurobiology of Affiliation: Implications for Autism Spectrum Disorders; 17. Neurobiology of Aggression 
505 8 |a 18. Neurobiology of Eating Disorders19. Neurobiology of Substance Abuse and Dependence Disorders; SECTION II: SOMATIC INTERVENTIONS; II-A: PSYCHOTROPIC AGENTS; 20. Stimulants; 21. Adrenergic Agonists: Clonidine and Guanfacine; 22. Antidepressants I: Selective Serotonin Reuptake Inhibitors; 23. Antidepressants II: Tricyclic Agents; 24. Antidepressants III: Other Agents; 25. Mood Stabilizers: Lithium and Anticonvulsants; 26. Antipsychotic Agents: Traditional and Atypical; 27. Anxiolytics: Benzodiazepines, Buspirone, and Others; 28. Miscellaneous Compounds: Beta-Blockers and Opiate Antagonists 
505 8 |a II-B: OTHER SOMATIC INTERVENTIONS29. Complementary and Alternative Medicine in Pediatric Psychopharmacology; 30. Electroconvulsive Therapy and Transcranial Magnetic Stimulation; SECTION III: ASSESSMENT AND TREATMENT; III-A: GENERAL PRINCIPLES; 31. Clinical Assessment of Children and Adolescents Treated Pharmacologically; 32. Clinical Instruments and Scales in Pediatric Psychopharmacology; 33. Thinking About Prescribing: The Psychology of Psychopharmacology; 34. Combining Pharmacotherapy and Psychotherapy: An Evidence-Based Approach; III-B: SPECIFIC DISORDERS AND SYNDROMES 
505 8 |a 35. Attention-Deficit Hyperactivity Disorder36. Depressive Disorders; 37. Bipolar Disorder; 38. Anxiety Disorders; 39. Obsessive-Compulsive Disorder; 40. Tourette's Syndrome and Other Tic Disorders; 41. Early-Onset Schizophrenia; 42. Autistic and Other Pervasive Developmental Disorders; 43. Post-traumatic Stress Disorder; 44. Eating Disorders; III-C: SPECIAL CLINICAL POPULATIONS; 45. Substance-Abusing Youths; 46. Individuals with Mental Retardation; 47. The Medically Ill Child or Adolescent; 48. Psychopharmacology During Pregnancy: Infant Considerations 
520 |a This is a comprehensive text on the use of medication in the treatment of children and adolescents with serious neuropsychiatric disorders. It reconciles recent research findings with good clinical practice. 
588 0 |a Print version record. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Pediatric psychopharmacology. 
650 0 |a Psychotropic drugs. 
650 0 |a Children. 
650 0 |a Psychopharmacology. 
650 1 2 |a Mental Disorders  |x drug therapy 
650 2 2 |a Child 
650 2 2 |a Psychopharmacology 
650 2 2 |a Psychotropic Drugs  |x therapeutic use 
650 2 |a Psychotropic Drugs 
650 7 |a children (people by age group)  |2 aat 
700 1 |a Martin, Andrés,  |e editor. 
758 |i has work:  |a Pediatric psychopharmacology (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCGF4bDdBfCpvQrfFDk4CV3  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |t Pediatric psychopharmacology.  |d Oxford ; New York : Oxford University Press, ©2003  |z 0195141733  |w (DLC) 2002022460  |w (OCoLC)49221932 
852 |b E-Collections  |h ProQuest 
856 4 0 |u https://ebookcentral.proquest.com/lib/mcphs/detail.action?docID=281481  |z Full text (MCPHS users only)  |t 0 
938 |a YBP Library Services  |b YANK  |n 20445602 
938 |a Internet Archive  |b INAR  |n pediatricpsychop0000unse_2003 
938 |a EBL - Ebook Library  |b EBLB  |n EBL281481 
938 |a ebrary  |b EBRY  |n ebr10269102 
938 |a EBSCOhost  |b EBSC  |n 146874 
938 |a Internet Archive  |b INAR  |n pediatricpsychop0000unse 
938 |a YBP Library Services  |b YANK  |n 2380842 
938 |a YBP Library Services  |b YANK  |n 2935407 
938 |a Askews and Holts Library Services  |b ASKH  |n AH24085556 
947 |a FLO  |x pq-ebc-base 
999 f f |s a3cecb84-ba90-4e09-b13a-770c95d905dc  |i c88a9d71-bf2b-4581-9a63-bc87a9b66013  |t 0 
952 f f |a Massachusetts College of Pharmacy and Health Sciences  |b Online  |c Online  |d E-Collections  |t 0  |e ProQuest  |h Other scheme 
856 4 0 |t 0  |u https://ebookcentral.proquest.com/lib/mcphs/detail.action?docID=281481  |y Full text (MCPHS users only)